DNA-security company Applied DNA Sciences this week said it has opened a marketing and sales office in London, and appointed
Baron Frederick Charles von Nidda
as general manager.
Von Nidda, a partner in the European-advisory firm GA Associates, has recently helped with the finance and expansion of a number of independent businesses, including the engineering firm Minimould, the pharma company Res-Del International, the medical firm Clinical Research Centres International; and the media concern Tri-Continental Films.
Gene Logic of Gaithersburg, Md., today announced the completion of its $52 million acquisition of TherImmune Research.
Gene Logic paid TherImmune shareholders approximately $30.9 million in cash, and issued 4 million shares of common stock, with a value of approximately $21.2 million, based on the closing price of its stock.
The company announced the acquisition in February.
The UK Biobank has appointed as CEO John Newton, a consultant in epidemiology at University of Oxford’s unit of health care epidemiology.
The UK Biobank funders are composed of the Medical Research Council, the Wellcome Trust, and the UK Department of Health.